Hornicek FJ

ORCID: 0000-0002-6916-8042 · 2 papers in corpus

2020

ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer.

Therapeutic advances in medical oncology ·doi:10.1177/1758835920982853

BackgroundAlthough ataxia-telangiectasia and Rad3 related (ATR) has an established role in the DNA damage response of various cancers, its clinical and prognostic significance in ovarian cancer remains largely unknown. The aims of this stud…

2009

Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas.

International journal of radiation oncology, biology, physics ·doi:10.1016/j.ijrobp.2008.08.058

PurposeRadiotherapy (XRT) for spine sarcomas is constrained by spinal cord, nerve, and viscera tolerance. Negative surgical margins are uncommon; hence, doses of >or=66 Gy are recommended. A Phase II clinical trial evaluated high-dose photo…